NIVOLUMAB,BRENTUXIMAB
BMS,SEAGEN
['check,mate,744', 'nivo', 'lymsm', 'checkmate 744']
congress| #asco23 paul harker-murray summarizes checkmate 744, a study evaluating salvage treatment with nivo + bv in children and adults with r/r chl. results demonstrate that most patients with low-risk r/r chl can be salvaged with chemoimmunotherapy. #lymsm 
A global education platform providing clinical updates on a range of lymphoma subtypes and chronic lymphocytic leukemia (#CLL) #lymsm